ResMed CEO sells Alpha Vantage · Investing.com · · AI-summarised by FinFlash
ResMed (NYSE: RMD) Chairman and CEO Michael Farrell sold 4,991 shares of the company's common stock for over Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · Investing.com · · AI-summarised by FinFlash
ResMed (NYSE: RMD) Chairman and CEO Michael Farrell sold 4,991 shares of the company's common stock for over Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context